Clinical Trials Directory

Trials / Completed

CompletedNCT01534533

Effects of Lutein Supplementation on Subclinical Atherosclerosis

The Effects of Lutein Supplementation on Subclinical Atherosclerosis

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
192 (actual)
Sponsor
Peking University · Academic / Other
Sex
All
Age
45 Years – 68 Years
Healthy volunteers
Accepted

Summary

This study is to investigate the possible positive effects of lutein and lycopene supplementation on early atherosclerosis in Beijing.

Detailed description

Atherosclerosis is the primary cause of cardiovascular and cerebrovascular diseases, both of which are the top two causes of death in industrialized countries including China. Lutein was found to be protective against atherosclerosis in some case control studies. However, the intervention on atherosclerosis have not been reported. In the present study, 192 subjects were randomly assigned to four groups treated with different amounts of lutein. The investigators observe the changes of serum lutein concentration by hyper-pressure liquid chromatography (HPLC), and compare the differences of common carotid IMT and arterial stiffness by carotid ultrasonography before and after the intervention. Serum biochemistry indexes including cholesterol (CHO), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C) and glucose (Glu) were measured at 0, 7 and 12 months of treatment by auto-analyzer.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboone gelatine capsule containing starch per day, for 12 months
DIETARY_SUPPLEMENTLutein groupone gelatine capsule containing 20mg lutein per day, for 12 months
DIETARY_SUPPLEMENTCombination groupone gelatine capsule containing 20mg lutein and 20 mg lycopene per day, for 12 months
DIETARY_SUPPLEMENTNormal lutein control groupsubjects without early atherosclerosis, treated with one gelatine capsule containing 20mg lutein per day, for 12 months

Timeline

Start date
2010-06-01
Primary completion
2011-06-01
Completion
2012-06-01
First posted
2012-02-16
Last updated
2013-07-22
Results posted
2012-10-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01534533. Inclusion in this directory is not an endorsement.